Revenue: The sum of all revenue fields included for a company's operating activities.
Navidea Biopharmaceuticals, Inc. (NAVB) had Revenue of $0.07M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
|
Revenue |
$0.07M |
$-17.21M |
|
$0.18M |
|
$-0.12M |
|
$14.12M |
|
$-14.05M |
|
$-1.13M |
|
$-15.18M |
|
$-15.18M |
|
$-15.18M |
|
$-15.18M |
|
$-15.18M |
|
$-15.18M |
|
$-14.05M |
|
$-13.77M |
|
30.90M |
|
30.90M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$3.20M |
|
$0.14M |
|
$1.17M |
|
$4.37M |
|
$9.94M |
|
$1.87M |
|
$2.57M |
|
$12.51M |
|
$-8.14M |
|
$-9.14M |
|
$-8.14M |
|
32.69M |
|
| Cash Flow Statement Financials | |
$-8.99M |
|
$-0.39M |
|
$7.14M |
|
$4.23M |
|
$2.00M |
|
$-2.23M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.32 |
|
-- |
|
-- |
|
-0.30 |
|
-0.30 |
|
-181.71% |
|
-21402.08% |
|
-21402.08% |
|
-20977.38% |
|
-23117.59% |
|
-26221.65% |
|
$-9.05M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.43 |
|
-- |
|
-- |
|
186.38% |
|
165.99% |
|
-347.18% |
|
242.00% |
|
$-0.25 |
|
$-0.29 |
|
$-0.29 |
|